Doxorubicin and edelfosine lipid nanoparticles are effective acting synergistically against drug-resistant osteosarcoma cancer cells.
Cancer Lett
; 388: 262-268, 2017 03 01.
Article
in En
| MEDLINE
| ID: mdl-27998763
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Phospholipid Ethers
/
Doxorubicin
/
Osteosarcoma
Limits:
Humans
Language:
En
Journal:
Cancer Lett
Year:
2017
Type:
Article
Affiliation country:
Spain